Protagonist Therapeutics, Inc. (PTGX)

85.23 +3.87 (+4.76%) USD  |  NASDAQ  |  Jan 14, 16:00
85.19 -0.04 (-0.05%) After-Hours: 20:00
More

Protagonist Therapeutics EBITDA Margin Estimates for Current Quarter

EBITDA Margin Estimates for Current Quarter Chart

View EBITDA Margin Estimates for Current Quarter for PTGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA Margin Estimates for Current Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Margin Estimates for Current Quarter Range, Past 5 Years

View EBITDA Margin Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA Margin Estimates for Current Quarter Benchmarks

View EBITDA Margin Estimates for Current Quarter Benchmarks
Start Trial
Johnson & Johnson Upgrade
ADMA Biologics, Inc. Upgrade
Bristol Myers Squibb Co. --
MannKind Corp. --
Regeneron Pharmaceuticals, Inc. Upgrade